Yıl: 2019 Cilt: 24 Sayı: 4 Sayfa Aralığı: 530 - 535 Metin Dili: İngilizce DOI: 10.5505/ejm.2019.63626 İndeks Tarihi: 17-04-2020

Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP

Öz:
Ventilator-associated pneumonia (VAP) is a nosocomial infection that can develop in patients receiving mechanical ventilator(MV) support. VAP has a high mortality rate and cost due to prolonged hospitalisation. Some procedures have s hown that VAPcan be prevented. However, the incidence of VAP is still high in Turkey. In this study, we aim to investigate how increasedcompliance with VAP prevention bundle training for health personnel affects the incidence of VAP, the onset day of VAP , theduration of mechanical ventilation, and mortality rates.This prospective case control study was started after obtaining permission from the Van Yuzuncu Yil University (VYYU)Medicine School Ethics Committee. It was conducted between November 2017 and June 2018 at the Anesthesiology andReanimation Intensive Care Unit (ICU) of the Dursun Odabaş Medical Center, VYYU Medicine School. In this study, the studygroup (VAP prevention bundle group after healthcare staff training) included 68 patients who rec eived MV support. The controlgroup consisted of 100 patients who received the VAP prevention bundle between January 2016 and June 2017 in the anaesthesiaICU. The Centers for Disease Control and Prevention (CDC) criteria were used for the diagnosis of VAP. In both groups,compliance with the Prevention Bundle, the incidence of VAP, the onset day of VAP, the duration of mechanical ventilation, th eday of tracheostomy operation and mortality rates were recorded. Patient groups were compared statistically.The demographic data, diagnosis and cultured microorganisms in VAP patients were similar and there was no statisticallysignificant difference. The effect of four parameters [Endotracheal tube with subglottic secretion drainage (SSD -ETT), 0.12%chlorhexidine oral care, peptic ulcer prophylaxis and deep venous thrombosis (DVT) prophylaxis] that were included in the VAPPrevention bundle could not be evaluated separately because of the mean fit. The mean fit in holding the bed head position at anangle of 30°–45° was 100% in the VAP Prevention bundle group, while in the control group the average was 90.67% (85 -100%).The relationship between this and the development of VAP was statistically significant (p=0.036). ETT cuff pressure of 20 –25cm H2O was maintained at 97.96% in the VAP Prevention Bundle group and at 93.13% in the control group . The differencebetween the groups according to the accordance to the ETT cuff pressure was statistically significant (p=0.01). In our study, VAPwas detected in 12 patients (17.6%) in the study group and 9 patients (9%) in the control group. There was no statisticallysignificant difference between the groups in terms of VAP or the duration of mechanical ventilation support(30.29 ± 24.5/26.11±15.47). No early development of was seen in either group (first four days after MV support). It wasdetermined that all VAP attacks developed after the fifth day of MV support. For 1000 ventilator days, onset of VAP was 13.1days in the VAP prevention bundle group and 4.29 days in the control group, which was not statistically significant (p = 0.96 ).Although the mean number of days of VAP-developing groups in relation to MV was 44.83 ± 30.845/82.22 ± 55.432, it was notstatistically significant. In the VAP prevention bundle group, the mean day of application of tracheostomy was 7.09 ± 7.12 whileit was 16.67 ± 9.11 in the control group; this difference between the groups was statistically significant. Although the mortalityrate was increased in patients with VAP, it was not statistically significant. However, mortality rates were significantly lo wer inpatients without VAP as compared to the control group (p<0.05).Implementation of the VAP prevention bundle group did not decrease the incidence of VAP in our clinic. It was found that stri ctcompliance to the all parameters of the prevention bundle didn’t reduce the VAP incidence in ICUs but it was prolonged theonset time of VAP. But the carrying out the VAP prevention bundle to the patients with mechanical ventilatory support reducedthe mortality rates. We think that the present VAP prevention bundle should be revised in the way of use of stress ulcerprophylaxis.
Anahtar Kelime:

Konular: Diş Hekimliği Toksikoloji Farmakoloji ve Eczacılık
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Torres A, Ferrer M, Badia JR. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis 2010; 51: 48-53.
  • 2. Dizbay M. Yoğun Bakımda Önlem Paketleri: Ventilatörle ilişkili Pnömoni. Hastane İnfeksiyonları Dergisi 2012; 16: 167-182.
  • 3. Jarvis WR. The Lowbury Lecture. The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from bench marking to zero tolerance and clinician accountability. J Hosp Infect 2007; 65: 3-9.
  • 4. Lorente L, Blot S, Rello J. Evidence on measures for the prevention of ventilator-associated pneumonia. Eur Respir J 2007; 30: 1193-1207.
  • 5. Coffin SE, Klompas M, Classen D, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29: 31-40.
  • 6. Rosenthal VD, Bijie H, Maki DG, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009 2012; 40: 396-407.
  • 7. American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
  • 8. Bouza E, Pérez MJ, Munoz P, Rincón C, Barrio JM, Hortal JJC. Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery 2008; 134: 938-946.
  • 9. Bird D, Zambuto A, O’Donnell C, et al. Adherence to ventilator-associated pneumonia bundle and incidence of ventilator-associated pneumonia in the surgical intensive care unit. Arch Surg 2010; 145: 465-470.
  • 10. Bonvicini D, Labate D, Benacchio L, Olivieri A, Pizzirani E. Type of stress-ulcer prophylaxis and incidence of ventilator-associated pneumonia. Intensive Care Med Exp 2016; 4: 251-607.
  • 11. Alhazzani, Waleed, Belley-Cote E, et al. "Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med 2018; 44: 1-11.
APA Andıç O, Demirkiran H, YARDIMCI C (2019). Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. , 530 - 535. 10.5505/ejm.2019.63626
Chicago Andıç Okan,Demirkiran Hilmi,YARDIMCI CEVDET Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. (2019): 530 - 535. 10.5505/ejm.2019.63626
MLA Andıç Okan,Demirkiran Hilmi,YARDIMCI CEVDET Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. , 2019, ss.530 - 535. 10.5505/ejm.2019.63626
AMA Andıç O,Demirkiran H,YARDIMCI C Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. . 2019; 530 - 535. 10.5505/ejm.2019.63626
Vancouver Andıç O,Demirkiran H,YARDIMCI C Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. . 2019; 530 - 535. 10.5505/ejm.2019.63626
IEEE Andıç O,Demirkiran H,YARDIMCI C "Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP." , ss.530 - 535, 2019. 10.5505/ejm.2019.63626
ISNAD Andıç, Okan vd. "Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP". (2019), 530-535. https://doi.org/10.5505/ejm.2019.63626
APA Andıç O, Demirkiran H, YARDIMCI C (2019). Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. Eastern Journal of Medicine, 24(4), 530 - 535. 10.5505/ejm.2019.63626
Chicago Andıç Okan,Demirkiran Hilmi,YARDIMCI CEVDET Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. Eastern Journal of Medicine 24, no.4 (2019): 530 - 535. 10.5505/ejm.2019.63626
MLA Andıç Okan,Demirkiran Hilmi,YARDIMCI CEVDET Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. Eastern Journal of Medicine, vol.24, no.4, 2019, ss.530 - 535. 10.5505/ejm.2019.63626
AMA Andıç O,Demirkiran H,YARDIMCI C Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. Eastern Journal of Medicine. 2019; 24(4): 530 - 535. 10.5505/ejm.2019.63626
Vancouver Andıç O,Demirkiran H,YARDIMCI C Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP. Eastern Journal of Medicine. 2019; 24(4): 530 - 535. 10.5505/ejm.2019.63626
IEEE Andıç O,Demirkiran H,YARDIMCI C "Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP." Eastern Journal of Medicine, 24, ss.530 - 535, 2019. 10.5505/ejm.2019.63626
ISNAD Andıç, Okan vd. "Training Healthcare Staff on Ventilator-Associated Pneumonia (VAP) Prevention Bundle and Its Effects on VAP". Eastern Journal of Medicine 24/4 (2019), 530-535. https://doi.org/10.5505/ejm.2019.63626